Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,070
Total Claims
$778K
Drug Cost
572
Beneficiaries
$1,359
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-91%
Opioid rate vs peers
0.2% vs 2.2% avg
-4%
Cost per patient vs peers
$1,359 vs $1,411 avg
+33%
Brand preference vs peers
14.1% vs 10.6% avg
Opioid Prescribing
0.2%
Opioid Rate
22
Opioid Claims
$202
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,563 claims · $542K
Generic: 9,489 claims · $235K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 307 | $116K |
| Semaglutide | 51 | $72K |
| Linagliptin | 34 | $32K |
| Empagliflozin | 13 | $22K |
| Rivaroxaban | 67 | $21K |
| Insulin Aspart | 109 | $21K |
| Sitagliptin Phosphate | 55 | $20K |
| Linaclotide | 17 | $16K |
| Lipase/Protease/Amylase | 51 | $13K |
| Cyclosporine | 28 | $12K |
| Glucagon | 11 | $11K |
| Evolocumab | 16 | $10K |
| Potassium Chloride | 159 | $10K |
| Atorvastatin Calcium | 720 | $9,265 |
| Budesonide/Formoterol Fumarate | 18 | $9,257 |
Prescribing Profile
Patient Profile
74
Avg Age
57%
Female
1.70
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data